Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Pharmedica USA, LLC
WARNING LETTER
•Pharmedica USA, LLC•November 7, 2022

Pharmedica USA, LLC – FDA Warning Letter, Nov 7, 2022

Record Details

On April 28, 2023, the FDA issued a Warning Letter to Pharmedica USA, LLC, following an inspection from November 1-7, 2022. The facility's drug products were deemed adulterated under 21 U.S.C. 351(a)(2)(A) due to insanitary conditions, specifically lacking ISO-classified areas for sterile drug manufacturing and being in disrepair. The products were also adulterated under 21 U.S.C. 351(a)(2)(B) for significant Current Good Manufacturing Practice (CGMP) violations.

Key violations included: 1. Failure to establish and follow written procedures for preventing microbiological contamination of sterile drug products, including validation of aseptic and sterilization processes (21 CFR 211.113(b) & 211.42(c)(10)). The firm manufactured multi-dose, preservative-free ophthalmic products without adequate controls, and admitted unawareness of sterility requirements for eye drops. 2. Failure to establish adequate written procedures for production and process control, including equipment qualification and process validation (21 CFR 211.100(a)). 3. Failure to conduct appropriate laboratory determination of conformance to final specifications, including sterility testing for sterile products and testing for objectionable microorganisms (21 CFR 211.165(

Company
Pharmedica USA, LLC
Inspection date
November 7, 2022
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations IV
People
  • Steven E. Porter (Program Division Director)
  • Mohamed Khalil
View Company Profile

ID · 90d307e2-6608-4ad5-8021-89bfd4c32b95

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 351(a)(2)(A)21 CFR 21021 CFR 21121 CFR 211.113(b)21 CFR 211.42(c)(10)21 CFR 211.100(a)21 CFR 211.165(a)21 CFR 211.165(b)21 CFR 211.84(d)(1)

Full citation text and observation details available on the Dashboard.

Other documents for Pharmedica USA, LLC
  • 483 - 2022-11-07November 7, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmedica USA, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.